The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder

Código QR

The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder

Maurizio Pompili1,2, Paola Venturini1, Marco Innamorati1, Gianluca Serafini1, Ludovica Telesforo1, David Lester3, Roberto Tatarelli1, Paolo Girardi11Department of Neurosciences, Mental Health and Sensory Functions, Suicide Prevention Center, Sant&#39;Andrea Hospital, Sapienza University of R...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pompili M, Venturini P, Innamorati M, Serafini G, Telesforo L, Lester D, Tatarelli R, Girardi P
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/1e7894ae2a7c438c9f7cc8c8b22ab13d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Asenapine effects on individual Young Mania Rating Scale items in bipolar disorder patients with acute manic or mixed episodes: a pooled analysis
por: Cazorla P, et al.
Publicado: (2013)

Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder
por: Citrome L, et al.
Publicado: (2017)

Asenapine for bipolar disorder
por: Scheidemantel T, et al.
Publicado: (2015)

Post hoc analyses of asenapine treatment in pediatric patients with bipolar I disorder: efficacy related to mixed or manic episode, stage of illness, and body weight
por: Findling RL, et al.
Publicado: (2018)

Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients
por: Ann E Maloney, et al.
Publicado: (2010)

New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania
por: Warren CG, et al.
Publicado: (2013)

Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
por: Gao K, et al.
Publicado: (2013)

Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar&nbsp;I disorder
por: Delia Bishara, et al.
Publicado: (2009)

The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic or mixed episode
por: Findling RL, et al.
Publicado: (2014)

Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?
por: Maurizio Pompili, et al.
Publicado: (2008)

QT and P-wave dispersion during the manic phase of bipolar disorder
por: Gurok MG, et al.
Publicado: (2019)

The noradrenaline metabolite MHPG is a candidate biomarker between the depressive, remission, and manic states in bipolar disorder I: two long-term naturalistic case reports
por: Kurita M, et al.
Publicado: (2015)

Role of sublingual asenapine in treatment of schizophrenia
por: Citrome L
Publicado: (2011)

Bipolar disorder and neurophysiologic mechanisms
por: Simon M McCrea
Publicado: (2008)

Effects of Lithium Combined with Second-Generation Antipsychotics for the Treatment of Manic Episodes in Patients with Bipolar Disorder: A Naturalistic Study in China
por: Liu Y, et al.
Publicado: (2020)

The efficacy of Li in bipolar disorder
por: Lozano R, et al.
Publicado: (2013)

Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire Thai version
por: Waleeprakhon P, et al.
Publicado: (2014)

Correlates of current suicide risk among Thai patients with bipolar I disorder: findings from the Thai Bipolar Disorder Registry
por: Suttajit S, et al.
Publicado: (2013)

Ziprasidone in the treatment of mania in bipolar disorder
por: Stephen E Nicolson, et al.
Publicado: (2007)

Lurasidone as a potential therapy for bipolar disorder
por: Woo YS, et al.
Publicado: (2013)

Long-term treatment of bipolar disorder with a radioelectric asymmetric conveyor
por: Mannu P, et al.
Publicado: (2011)

Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder
por: A Carlo Altamura, et al.
Publicado: (2008)

Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism
por: Jean-Michel Azorin, et al.
Publicado: (2010)

Effects, experiences, and impact of stigma on patients with bipolar disorder
por: Mileva VR, et al.
Publicado: (2013)

Role of extended release quetiapine in the management of bipolar disorders
por: Rayan K Al Jurdi, et al.
Publicado: (2010)

Evidence for single nucleotide polymorphisms and their association with bipolar disorder
por: Szczepankiewicz A
Publicado: (2013)

The role of paliperidone extended release for the treatment of bipolar disorder
por: Marino J, et al.
Publicado: (2012)

Risperidone treatment for ADHD in children and adolescents with bipolar disorder
por: Joseph Biederman, et al.
Publicado: (2008)

Korean Medication Algorithm Project for Bipolar Disorder: third revision
por: Woo YS, et al.
Publicado: (2015)

Insight in bipolar disorder: relationship to episode subtypes and symptom dimensions
por: Frederick Cassidy
Publicado: (2010)

Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
por: El-Khalili N
Publicado: (2012)

Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
por: Jeffrey R Bishop, et al.
Publicado: (2008)

Extended-release divalproex in bipolar and other psychiatric disorders: A comprehensive review
por: Steven C Stoner, et al.
Publicado: (2007)

Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in schizophrenia
por: Mackle M, et al.
Publicado: (2012)

Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
por: Prashant Gajwani, et al.
Publicado: (2007)

Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence
por: McIntyre R, et al.
Publicado: (2011)

Depressive mixed state: Evidence for a new form of depressive state in type I and II bipolar patients
por: Katia M&rsquo;Bailara, et al.
Publicado: (2007)

Early stages of pediatric bipolar disorder: retrospective analysis of a Czech inpatient sample
por: Goetz M, et al.
Publicado: (2015)

Facial expression in patients with bipolar disorder and schizophrenia in response to emotional stimuli: a partially shared cognitive and social deficit of the two disorders
por: Bersani G, et al.
Publicado: (2013)

Memantine induces manic episode in a 73-year-old patient with vascular neurocognitive disorder: a case report
por: Duan JF, et al.
Publicado: (2018)